Novel Therapeutic Target(s) for Psoriatic DiseaseReview Published on 2022-02-212024-09-02 Journal: Frontiers in Medicine [Category] 대상포진, [키워드] Autoimmune hepatitis biologics and biosimilars infliximab monotherapy psoriasis psoriatic arthritis small molecule Treatment [DOI] 10.3389/fmed.2022.712313 PMC 바로가기 [Article Type] Review
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published EvidenceResearch article Published on 2022-02-012022-10-05 Journal: The Journal of investigative dermatology [Category] COVID19(2023년), SARS, 치료법, [키워드] analyzed appraisal Assessing biologic COVID-19 COVID-19 in patient Evidence high risk information internal and external Major median methodological Newcastle-Ottawa Scale NOSNewcastle-Ottawa Scale outcome Participants Patient positive swab provided PsApsoriatic arthritis Psopsoriasis psoriasis psoriatic arthritis Quality receiving reduction risk risk of bia risk of COVID-19 Sample size SARS-CoV-2severe acute respiratory syndrome coronavirus 2 selected severe acute respiratory syndrome coronavirus 2 Spread Statistical power Therapies Validity was used [DOI] 10.1016/j.jid.2021.04.036 [Article Type] Research article
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases류마티스 질환 환자에서 백신 접종에 대한 약화된 항-SARS-CoV-2 항체 반응Article Published on 2022-02-012022-09-12 Journal: The Journal of Infection [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract anti-SARS-CoV-2 antibody COVID-19 IMID methotrexate mRNA vaccine Patient psoriatic arthritis response to vaccination rheumatic disease Rheumatoid rheumatoid arthritis SARS-CoV-2 spondyloarthritis vaccination Viral vector vaccine [DOI] 10.1016/j.jinf.2021.12.006 PMC 바로가기 [Article Type] Article
Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 InfectionCOVID-19 감염에 의해 유발된 난치성 건선성 관절염에 대한 Certolizumab Pegol의 성공적인 사용Case Reports Published on 2022-02-012022-09-12 Journal: Internal medicine (Tokyo, Japan) [Category] MERS, 진단, [키워드] acute respiratory syndrome Arthritis Autoimmune caused certolizumab pegol coronavirus coronavirus disease COVID-19 develop glucocorticoid induce manifestation methotrexate mild-to-moderate disease Patient poor prognosis psoriatic arthritis reactive refractory severe acute respiratory syndrome coronavirus 2 Spread triggered viral infection [DOI] 10.2169/internalmedicine.8643-21 PMC 바로가기 [Article Type] Case Reports
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologistsReview Article Published on 2022-01-262023-06-14 Journal: Clinical Rheumatology [Category] MERS, [키워드] Clinical practice Dermatology psoriatic arthritis rheumatology Telemedicine [DOI] 10.1007/s10067-022-06077-3 PMC 바로가기 [Article Type] Review Article
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccineResearch Article Published on 2022-01-112022-10-28 Journal: Arthritis Research & Therapy [Category] COVID-19, SARS, [키워드] adverse event anti-SARS-CoV-2 connective tissue Control control group controls COVID-19 disease dose evaluated event example female Fever first dose Follow-up Frequency healthy control immunization immunosuppressants incidence rate Inflammatory arthritis inhibitor injection investigated joint Local Logistic regression analysis low frequency males median median age Mild MOST mRNA vaccine Musculoskeletal occurred Occurrence Pain Patient patients pauci-symptomatic performed psoriatic arthritis reactogenicity remained reported Result Rheumatic musculoskeletal disease rheumatoid arthritis SARS-CoV-2 SARS-CoV-2 vaccination second dose subject supplementary material Symptom therapy Treatment vaccination Vaccine vaccine administration was recorded women [DOI] 10.1186/s13075-021-02674-w PMC 바로가기 [Article Type] Research Article
Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort StudyCommunication Published on 2021-12-282022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% confidence interval Administered age Antibody Response Antibody test baseline biologic Bloods BNT162b2 vaccine Booster vaccine Cambridge Clinical data collected Combination combination therapy COVID-19 pandemic COVID-19 vaccine cut-off defined detection determine disease Disease activity drug Efficacy Gender Germany Healthcare provider Humoral response IgG IgG level IgG response immune response Immunoglobulin information Interim Mainz median medians Moderna mRNA-1273 vaccine Musculoskeletal National Outpatient Patient patient reported outcome patients treated Pfizer Prospective prospective cohort study psoriatic arthritis receiving report reported response Result rheumatoid arthritis risk RMD SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 vaccination SARS-CoV-2 vaccine significant increase significantly higher significantly lower study population tested the median the SARS-CoV-2 Thermofisher treated Treatment USA vaccination Vaccine was measured was used were used [DOI] 10.3390/vaccines10010035 PMC 바로가기 [Article Type] Communication
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single CenterMedicine Published on 2021-12-232022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] age Antigen association attacked AZD1222 baseline benefit biologics center Comorbidities contraindication Control control group COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines disease Disease activity dose Exacerbation fatality fluctuation genotypes HLA human leukocyte antigen immunized individual leukocyte mechanism Moderna mRNA-1273 pandemic era Patient patients physician pre-vaccination psoriasis psoriatic arthritis receiving recruited report reported Severe COVID-19 Infection severity Sex Th17 Th17 cell therapy treatable vaccinated against COVID-19 vaccination Vaccine Vaccines worsening [DOI] 10.3389/fmed.2021.812010 PMC 바로가기 [Article Type] Medicine
Prevalence of Depressive Symptoms in Patients With Psoriatic Arthritis: Have Numbers Changed During the COVID-19 Pandemic?Medicine Published on 2021-11-012022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] activity addition Analysis analyzed Arthritis Complete COVID-19 COVID-19 pandemic Depression depressive symptom Depressive symptoms Disease activity evaluate Frequency Germany healthcare identify information Local lockdown longitudinal analysis Longitudinal data National not differ number pandemic Patient Patient care PHQ-2 Prevalence prevalence rate psoriatic arthritis resulting Rheumatic diseases SARS-CoV-2 SARS-COV-2 infection score sensitivity analysis the patient [DOI] 10.3389/fmed.2021.748262 PMC 바로가기 [Article Type] Medicine
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDTNFi는 긍정적인 결과와 관련이 있지만 JAKi와 rituximab은 RMD 환자에서 SARS-CoV-2 감염의 부정적인 결과와 관련이 있습니다.Article Published on 2021-10-012022-09-12 Journal: RMD Open [Category] 진단, [키워드] 95% CI analysed antirheumatic agents association cardiovascular disease Chronic kidney disease chronic lung disease collected Course COVID-19 COVID-19 severity Cyclophosphamide disease Disease activity feature glucocorticoid Glucocorticoids hospitalised hypertension Immunosuppressant Inflammatory influence inhibitor Janus kinase Male sex methotrexate MTX multivariable Musculoskeletal ordinal logistic regression outcome Patient patients died positive psoriatic arthritis rheumatoid arthritis risk factor SARS-COV-2 infection severe COVID-19 severity of COVID-19 TNF Treatment Ventilated [DOI] 10.1136/rmdopen-2021-001896 PMC 바로가기 [Article Type] Article